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Research Question and Abstract:
Why do two developing countries in the same region have vastly different
vaccination rates? What specific factors have the greatest influence on the
vaccination rates in differing developing nations? This papers objective is to use
a statistical model to try to determine what factors, education, healthcare system
and infrastructure, play the largest role in impacting both positively the measles
vaccination rate in 20 African countries. The results found only two of the six
variables originally chosen to be statistically significant. These variables were
the percentage of paved roads and the percentage of the GDP spent on
education.
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Introduction
Currently worldwide, almost 17% of all deaths in children ages 0-59
months old could be prevented by vaccinations. This percentage increases to
29% of all global deaths that could be prevented by vaccinations, if just looking at
children 1-59 months old (World Health Organization, 2012a). These deaths
occur from diseases such as measles, polio, hepatitis B and tetanus. Of these
deaths that occur, from vaccine preventable diseases, the majority are in
developing countries in Africa, South America or Asia. One disease that
exemplifies this discrepancy, between the developing world and the developed
world, is measles. According to the WHO, the “measles virus is highly infectious
and, in the prevaccination period, >90% of individuals were infected by the age of
10 years (World Health Organization, 2009a). Furthermore, more than 95% of
the annual deaths that occur from measles occur in developing nations that have
poor access to healthcare (World Health Organization, 2012b). These two
statistics show that the burden of the measles disease has manifested on the
people living in low-income, developing nations and the developed nations have
nearly eradicated measles. However, even in the developing world, there are
vast differences between the vaccination rates. For example, in Chad the
measles vaccination rate is 24% (World Health Organization, 20011e) while in
Ghana the measles vaccination rate is 93% (World Health Organization, 20011i).
The question becomes why do two developing countries in the same region have
vastly different vaccination rates? What specific factors have the greatest
influence on the vaccination rates in differing developing nations? This paper’s
objective is to use a statistical model to try to determine what factors, education,
healthcare system and infrastructure, play the largest role in impacting both
positively and negatively the measles vaccination rate in 20 African countries.
Many studies have been done concluding that measles has become a
disease of the poor (Costa, 2003, Henao-Restrepo, 2003 and Sabin, 1991). A
study in 2003 by Stein showed that 66% of the measles deaths occur in eleven of
the poorest countries due to poor healthcare services (Stein, 2003). Most of the
literature also agrees that measles is mostly present only in developing nations
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because of low levels of immunization: “The disease remains a major cause of
serious disease and mortality in many developing countries. This is largely
because of low vaccination coverage (Osterhaus, 1994). Expanding this
argument Glass states, “it is clear that unvaccinated children have a much
greater risk of infection when their local community has a low vaccination
coverage (Glass, 2004). Furthermore, a study done in Portugal after they
implemented a mass vaccination strategy concluded that “mass vaccination
strongly suppressed the disease incidence” and that the average age of infection
was higher (Gomes, 1999). A time series graph comparing global immunization
percentage to number of global case of measles from 1980- 2010 shows that the
two are inversely correlated (World Health Organization, 2011a). As the
percentage of immunization increase from under 20% in 1980 to over 80% in
2010, the number of global cases drops from over four million, in 1980, to under
five hundred thousand in 2010.
While it is clear that there is a link between immunization percentage and
number of cases, it is still unclear what the best way to increase vaccination
percentages is. In reviewing the literature there are a few differing opinions, or
combination of ideas that could help best increase the immunization percentage
in developing nations. The first is the need for improvement of the healthcare
system. This includes increasing the number of well-trained healthcare personal
(Nelson, 2007 and Croghan, 2006) and increasing the surveillance and record
systems to ensure infants get vaccinated (Munyoro, 2003 and Cuuts, 1994). The
second main improvement is to increase the education because there is a lack of
knowledge both about the importance and availability of vaccinations. In some of
the countries there are programs in place, however the citizens simply don’t
know about the program or chose not to partake because they don’t know the
benefits a vaccine can provide (Smith, 1996 and Cochran, 2000). Furthermore,
providing education can help both sustain and inform the public about current
programs (Gay, 2004). Increasing education would allow citizens to get the most
out of their country’s current healthcare system.
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The third major opinion discussed in the literature is increasing the
infrastructure of countries. The argument made is that in many countries the
rural population has little to no access to healthcare because they cannot simply
get to the healthcare facilities (Larson, 2003, Crogan, 2006 and Rahman, 1999).
In Zimbabwe, when the government implemented an Expanded Program on
Immunization in 1981, it overcame the lack of infrastructure, roads, by having a
small fleet of cars that would go to differing suburbs or rural villages to give the
vaccinations. This method was very effective at getting vaccinations to the
population despite the lack of infrastructure; the country had coverage upwards
of 90% at its peak. However, by 1995 the immunization levels started to decline
do to an “aging fleet of cars” (Munyoro, 2003). This example exemplifies the
necessity of infrastructure in order to improve access to the available healthcare.
Other authors stated that improvement in infrastructure was necessary, but it was
not the need for more roads, however the need for better housing. The likelihood
of an outbreak in overcrowded houses without ventilation is much higher; these
are the conditions that are often seen in developing nations (Orenstien, 2006).
The literature concludes that while most agree that to eliminate measles,
vaccination is the best method, the best way to increase the immunization levels
in the world’s developing counties is still up for debate. Most experts believe it is
best done by; either creating a more complete healthcare system, increasing
education especially relating to healthcare and vaccinations or increasing the
infrastructure of a nation to increase the availability of healthcare.
Methodology
Model
In order to find evidence on which factors lead to higher measles
vaccination rates, the follow regression was run using the ordinary least squares
method:
MV= F(C, ACW, PR, LE, HCE, HWC, EE, ALR)
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Where:
MV= Percentage of 1 year olds vaccinated against measles
C= a constant
ACW= Access to clean water, measured by percentage of people who
have a method to filter there water
PR= Percentage of total roads that are paved
LE= Life expectancy, measured in average years expected to live at birth
if current conditions are unchanged, between men and women
HCE= Healthcare expenditure, measured in US dollars per capita per year
HWF= Healthcare workforce, measured by the number of recorded
nurses, midwives and physicians for every 10,000 people
EE= Education expenditure, measured by percentage of total spending
annually towards education and education improvement
ALR= Adult literacy rate, measured in percentage of literate males and
females above the age of 15
These variables were chosen because they represent some aspect of the
three sectors identified by the preceding literature to help improve vaccination
rates: infrastructure, healthcare and education. While there is expected to be
some multicollinearity, when two or more of the variables are highly correlated,
these specific variables were chosen to try to create a more complete picture of
each of the represented sectors and are different enough that the multicollinearity
should not be too high. To represent infrastructure, access to clean water and
percentage of paved roads were chosen because both help measure a countries
level of infrastructure.
To represent the healthcare sector life expectancy, healthcare expenditure
and healthcare workforce were chosen as the variables. Life expectancy can give
a general view to the over all healthcare system because it is a common way to
measure quality of life and access to basic necessities. Healthcare expenditure
is used to represent the role the governement plays in improving healthcare
facilities and implementing governement programs to increase the populations
health. Healthcare workforce can be used to generally represent the access
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citizens have to healthcare in a given nation and training programs and schooling
for nurses and doctors the country may have to help improve access to and
quality of healthcare in the future.
To represent the education sector, government education expenditure and
adult literacy rate were chosen. Education expenditure can show the role of the
governement in creating access to education and can show if education is a
priority for the current regime in power. Adult literacy rate, represents the quality
of education, teachers’ ability, and can roughly show attendance levels. A higher
adult literacy rate means that more citizens attended school. The above
explanatory variables were chosen because each gives a slightly different insight
to the factor they are representing.
All of the explanatory variables are hypothesized to be positively
correlated with the measles vaccinations percentage. Meaning that an increase
in any of the explanatory variables should increase the percentage of the
population that is immunized against measles.
Data (Appendix #1)
Twenty differing African countries will be used when running this
regression. They were chosen from a variety of regions and half are categorized
as least developed nations and half as developing nations according to the World
Health Organization. The data for MV, ACW, LE, HCE, HWF were taken from
the World Health Organizations country reports. The newest report for each
country was used with the years ranging from 2009-2011. The data for PR was
taken from the CIA WorldFact book. The data for ALR and EE were taken from
the Worldbank. While sometimes figures can be misreported or bias using these
sources for data, the data is as accurate as possible.

Results
Scatter Plots of Measles Vaccinations v. Explanatory Variables (Appendix #2)
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Before running a regression it is important to plot all of the explanatory
variables against the dependent variable, measles vaccination to make sure that
a linear fit regression is appropriate for the model. All of the variables appear to
have a linear relationship; none of the explanatory variables appear to have an
exponential or logarithmic relationship. This means that a linear regression
model is appropriate. However, the relationship between the differing
explanatory variables and the percentage of measles vaccinations is not always
a strong linear relationship. The relationship is especially weak for life
expectancy and healthcare expenditure. However, those variables will be kept at
least for the first model to see their relevance in the estimated equation. Finally,
the scatter plots are important to make sure that there is not one data point that
is consistently an outlier that might change to overall results. When looking at
the graphs there is not one data point that is an outlier for a majority of the
scatter plots, so all of the data points will be kept.
Model #1
After running the regression the following equation was estimated:
MV[t] = +0.3178 ACW[t] +0.4594 PR[t] -0.4358 LE[t] -0.011HCE[t] -0.6615
HWF[t] +1.8292 EE[t] +0.5075 ALR[t] +11.1694 + C[t]

Variable Parameter
ACW[t]

S.E.

T-STAT

P-VALUE

0.31789

0.216871 1.465801 0.084205

PR[t]

0.459401

0.215576 2.131043 0.027227

LE[t]

-0.435858

0.600264 -0.72611 0.240847

HCE[t]

-0.010708

0.03388 -0.31605 0.378697

HWF[t]

-0.661528

EE[t]

1.82979

0.500225

1.322461

0.105333

0.650361 2.813498 0.007824
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ALR[t]

0.50875

0.211556 2.404806 0.016613

Constant 11.169458 31.837634 0.350826 0.365901

R-squared

0.805533

Adjusted R-squared 0.692094
F-TEST

7.101007

P-VALUE

0.001712

The major problem with this estimated equation is that all of the variables
that represent the healthcare factors have negative coefficients. This does not
make sense because increasing life expectancy, health expenditure and
healthcare work force should all increase the measles vaccination percentage by
increasing access.
Model #2
This regression was run without the LE explanatory variable because the
scatter plots showed that there was little to no correlation between LE and MV.
Furthermore, LE is such a complicated variable, that it may not accurately
represent only the healthcare sector. By excluding LE, hopefully the problem with
the negative coefficients from model #1 will be fixed.
The following regression was run, MV= F(C, ACW, PR, HCE, HWC, EE,
ALR) with the estimated equation:
MV[t] = +0.331ACW[t] +0.3494 PR[t] -0.00701 HCE[t] -0.78238518812533
HWC[t] +1.6979 EE[t] +0.5331ALR[t] -9.249 + C

Variable Parameter

S.E.

T-STAT

P-VALUE

ACW[t]

0.331017

0.21215 1.560296

0.071348

PR[t]

0.349442 0.150612 2.320145

0.01862

Jeff Judkins. Global Health and Development Policy, Geneva. 2 May 2012.

10

HCE[t]

-0.007067 0.032892 -0.214864

0.416604

HWC[t]

-0.782385 0.463065 -1.689581

0.057466

EE[t]

1.697932 0.613034

2.76972

0.007963

ALR[t]

0.533114 0.205044 2.599992

0.011003

Constant

-9.24898 14.655327

0.269457

R-squared

-0.6311

0.796989

Adjusted R-squared 0.703291
F-TEST

8.505967

P-Value

0.000683

This model still has the problem of the negative coefficient for both HCE
and HWC.
Model #3
Given the negative coefficients of HCE and HWC, both of those
explanatory variables were not included in the third regression: MV= F(C, ACW,
PR, EE, ALR).
The following equation was estimated:
MV[t] = +0.1393 ACW[t] +0.3881 PR[t] +1.3515 EE[t] +0.2563ALR[t] +15.1311 +
C[t]
Variable

T-STAT

Parameter

S.E.

P-VALUE

ACW[t]

0.139304

0.244004

0.570909

0.288258

PR[t]

0.388125

0.18093

2.145169

0.024359

EE[t]

1.351508

0.70865

1.907159

0.037918

ALR[t]

0.256251

0.21699

1.180932

0.128008
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Constant

15.131107

14.723453

1.027687

R-squared

0.657266

Adjusted R-squared

0.565871

F-TEST

7.191436

P-VALUE

0.001928

0.160192

Of the three regressions that were run, this is the first regression where
the coefficient signs were positive meaning the explanatory variables are
positively correlated with the percentage of the population that received the
measles vaccination which is logical.
Discussion
Analysis and Interpretation of Results
The first model produced an r-squared of 0.805 which is very high. It
means that there is a strong correlation between the seven explanatory variables
and the immunization coverage. With seven explanatory variables and a sample
size of only twenty, the r-squared value is probably overstated. To account for
the high number of variables, the adjusted r-squared is used. For this model the
adjusted r-squared is 0.692, which means there is, still a strong correlation
between the seven explanatory variables and the dependent variable. However,
this model is flawed because of the negative coefficients on the following
variables: LE, HCE and HWF. This raises concern because both the literature
reviewed and theory would suggest that increasing the life expectancy, the
healthcare expenditure or the number of people working the healthcare industry
would increase the percentage of the population that had received the measles
vaccination. To try to rid the model of these flaws a second regression was run,
however this time the LE variable was removed. The LE variable was removed
because the scatter plot MV v. LE showed there was little to no correlation and
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the life expectancy of a given country has countless variables that affect it. The
variables that can impact life expectancy go beyond the healthcare system, and
include living conditions, whether the country is in conflict, etc.
The second model produced a slightly lower r-squared, 0.79, but a slightly
higher adjusted r-squared, 0.703. This difference in r-squared can be attributed
to the fact that there is one less explanatory variable and the explanatory power
of the variables is only slightly lower. However, this model is still flawed because
the coefficients for HCE and HWF are still negative. As explained above the
negative correlation goes against the existing literature and the theory. A final
regression was run excluding HCE and HWF.
The final regression produced a much lower r-squared and adjusted rsquared, 0.657 and 0.566 respectively. This means that a correlation exists
between the final four explanatory variables and measles vaccination coverage.
And the model can explain about 65% of the change in immunization levels. This
drop in r-squared is probably because of an omitted variable. The likelihood of
an omitted variable in this final model is high because after removing LE, HCE
and HWF there are no variables left that represent the healthcare sector. The
results of the third regression also showed that two of the four final variables
were statistically significant when tested at the 5% level, using a t-test. Since the
p-values of for EE, 0.038, and PR, 0.024, are less than 0.05 level tested against,
it can be inferred that those two variables are statistically significant. Since the pvalues, 0.29 and 0.13 respectively, for ACW and ALR, are greater than 0.05 they
are found to not be statistically significant for at the 5% level.
The coefficients of EE and PR reveal that both are positively correlated
with measles vaccination, which is coherent with existing literature and theory.
The values of the coefficient explain how much a one-unit change in the
explanatory variable affects the dependent variable. For EE the coefficient is
1.35. This means that a one-unit change in EE, increasing the education
expenditure by one percent of gross domestic product will increase the
immunization percentage by 1.35% all other variables held constant. The
coefficient for PR is 0.39. Similarly, this means that a one-unit in PR, increasing
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the number of paved roads by one percent, will intern increase the immunization
coverage by 0.39%. However, it is important to not that just because an one
percent change in EE has a greater affect on MV than an one percent change in
PR does, it does not conclude that investing in education necessarily has greater
influence than investing in roads. This is because one percent of a country’s
gross domestic product could be more or less than the cost to increase the
percentage of paved roads by one percent. Without this data it is impossible to
conclude, investment in which of this variables would be a more efficient way to
increase the measles immunization percentage.
Overall, the final model broadly suggests that investment in both
education and infrastructure can have an impact on increasing the measles
vaccination coverage of a country’s population. More specifically, given the
variables tested, it shows that specific investment to increase roads and
education will increases the vaccination percentage. These two variables being
statistically significant makes sense because more roads allows more people in
the suburbs or rural areas to have access to urban clinics and hospitals that are
giving vaccinations and the more money spent on education, the more likely the
citizens are going to know the importance of vaccinations.
Limitations of Results
The results found in this study have a few limitations. First, the sample
size is very small, utilizing only data from twenty of the fifty-four African countries.
Because of this the results are not applicable to the whole region. Second, the
data collected for these variables can bias or inaccurate. When data is collected
by organizations or from governments the numbers can be inflated to make the
country appear better. This is specifically true with data for health and education
expenditure. If a countries governement is corrupt it can be difficult to see if the
money budgeted for health and education is actually being used for these
purposes. Data inaccuracies or bias are always a concern with studies like this,
however give the sources of the data, the data is as reputable as possible. Third,
the variables used to represent the healthcare sector were removed from the
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model because of negative coefficients. However, theory, existing literature and
common sense show that there is a direct link between the healthcare system of
a given country and the percentage of the population that is vaccinated in that
country. By not having the healthcare sector represented in this model is a major
limitation and can be seen by the decrease in the r-squared between model #2
and model #3. Finally, the given results show that there is a positive correlation
between education and measles vaccination percentage and infrastructure and
measles vaccination percentage. However, these results only show the
relationship between the explanatory variables and MV and do not show other
possible benefits that can occur with investment in either education or additions
to infrastructure. More research would have to be done to examine this other
possible benefits to figure out where investment would have the greatest overall
benefits to society. The results found give insight to measles vaccination, but
have some limitations.
Future Studies
Future studies that could expand these results include: looking at the
discrepancy between urban and rural care and the differences in availability of
vaccinations and healthcare, the difference between one dose of the measles
vaccination and two doses. Another possible study that more directly relates to
this paper is doing the same study with a larger sample size and possible looking
at another region as well such as South America or Asia. Finally, to complement
these results a study that looked at differing areas of the healthcare sector would
be important because both theory and literature suggest that a strong, positive
correlation should exist
Conclusion
It is imperative to increase the measles vaccination percentage in many
developing countries. This study shows that both increasing the levels of
education and infrastructure can both positively impact the measles vaccination
coverage. Increasing education can educate the public about both existing
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vaccination programs that may exist within a country and about the importance
and benefits of being vaccinated. Increasing infrastructure would provide access
to vaccination facilities to the population, that may not have an efficient, fast and
easy way of getting to said facilities, therefore possible forgoing the opportunity
to be vaccinated. By increasing both education and infrastructure in developing
nations the measles vaccination will increase, helping to eliminate a disease that
still plagues many developing nations.
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Appendices
Appendix #1
Data
Country: Algeria
MV: 77% (World Health Organization, 2011a)
ACW: 80% (World Health Organization, 2011a)
PR: 74% (CIA World Factbook, 2012a)
LE: 72 years (World Health Organization, 2011a)
HCE: $280 (World Health Organization, 2011a)
HWC: 31.6 (World Health Organization, 2011a)
EE: 2.6% (The World Bank, 2009b)
ALR: 84% (CIA World Factbook, 2012a)
Country: Angola
MV: 77% (World Health Organization, 2011b)
ACW: 48% (World Health Organization, 2011b)
PR: 10.4% (CIA World Factbook, 2012b)
LE: 52 years (World Health Organization, 2011b)
HCE: $200 (CIA World Factbook, 2012b)
HWC: 14.3 (World Health Organization, 2011b)
EE: 20.3% (CIA World Factbook, 2012b)
ALR: 70% (The World Bank, 2009a)
Country: Botswana
MV: 94% (World Health Organization, 2011c)
ACW: 92% (World Health Organization, 2011c)
PR: 35.3% (CIA World Factbook, 2012c)
LE: 61 years (World Health Organization, 2011c)
HCE: $600 (World Health Organization, 2011c)
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HWC: 31.8 (World Health Organization, 2011c)
EE: 25.1 (The World Bank, 2009b)
ALR: 84 (The World Bank, 2009a)
Country: Cameroon
MV: 74% (World Health Organization, 2011d)
ACW: 70% (World Health Organization, 2011d)
PR: 12.4% (CIA World Factbook, 2012d)
LE: 51 years (World Health Organization, 2011d)
HCE: $62 (World Health Organization, 2011d)
HWC: 17.9 (World Health Organization, 2011d)
EE: 17% (The World Bank, 2009b)
ALR: 71 % (The World Bank, 2009a)
Country: Chad
MV: 23% (World Health Organization, 2011e)
ACW: 42% (World Health Organization, 2011e)
PR: 0.8% (CIA World Factbook, 2012e)
LE: 48 years (World Health Organization, 2011e)
HCE: $48 (World Health Organization, 2011e)
HWC: 3.2 (World Health Organization, 2011e)
EE: 12.6% (The World Bank, 2009b)
ALR: 34% (The World Bank, 2009a)
Country: Congo
MV: 76% (World Health Organization, 2011f)
ACW: 72% (World Health Organization, 2011f)
PR: 9.7% (CIA World Factbook, 2012f)
LE: 55 years (World Health Organization, 2011f)
HCE: $71 (World Health Organization, 2011f)
HWC: 9.2 (World Health Organization, 2011f)
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EE: 12.6% (The World Bank, 2009b)
ALR: 67% (CIA World Factbook, 2012f)
Country: Democratic Republic of the Congo
MV: 76% (World Health Organization, 2011g)
ACW: 46% (World Health Organization, 2011g)
PR: 13.4% (CIA World Factbook, 2012g)
LE: 49 years (World Health Organization, 2011g)
HCE: $15 (World Health Organization, 2011g)
HWC: 6.4% (World Health Organization, 2011g)
EE: 13.2% (CIA World Factbook, 2012g)
ALR: 68% (The World Bank, 2009a)
Country: Ethiopia
MV: 75% (World Health Organization, 2011h)
ACW: 40% (World Health Organization, 2011h)
PR: 13.7% (CIA World Factbook, 2012g)
LE: 54 years (World Health Organization, 2011h)
HCE: $20 (World Health Organization, 2011h)
HWC: 2.6 (World Health Organization, 2011h)
EE: 23.3% (The World Bank, 2009b)
ALR: 30% (The World Bank, 2009a)
Country: Ghana
MV: 93% (World Health Organization, 2011i)
ACW: 81% (World Health Organization, 2011i)
PR: 29.6% (CIA World Factbook, 2012i)
LE: 60 years (World Health Organization, 2011i)
HCE: $62 (World Health Organization, 2011i)
HWC: 11.4 (World Health Organization, 2011i)
EE: 18.4% (The World Bank, 2009b)
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ALR: 67% (The World Bank, 2009a)
Country: Ivory Coast
MV: 67% (World Health Organization, 2011j)
ACW: 74% (World Health Organization, 2011j)
PR: 8.1% (CIA World Factbook, 2012j)
LE: 50 years (World Health Organization, 2011j)
HCE: $52 (World Health Organization, 2011j)
HWC: 6.2 (World Health Organization, 2011j)
EE: 21.7% (The World Bank, 2009b)
ALR: 55% (The World Bank, 2009a)
Country: Kenya
MV: 74% (World Health Organization, 2011k)
ACW: 62% (World Health Organization, 2011k)
PR: 14.1% (CIA World Factbook, 2012k)
LE: 60 years (World Health Organization, 2011k)
HCE: $30 (World Health Organization, 2011k)
HWC: 13.2 (World Health Organization, 2011k)
EE: 17.2% (The World Bank, 2009b)
ALR: 87% (The World Bank, 2009a)
Country: Malawi
MV: 92% (World Health Organization, 2011l)
ACW: 78% (World Health Organization, 2011l)
PR: 45% (CIA World Factbook, 2012l)
LE: 47 years (World Health Organization, 2011l)
HCE: $18 (World Health Organization, 2011l)
HWC: 3 (World Health Organization, 2011l)
EE: 12.1% (The World Bank, 2009b)
ALR: 74% (The World Bank, 2009a)
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Country: Mali
MV: 71% (World Health Organization, 2011m)
ACW: 43% (World Health Organization, 2011m)
PR: 18% (CIA World Factbook, 2012m)
LE: 53 years (World Health Organization, 2011m)
HCE: $38 (World Health Organization, 2011m)
HWC: 3.5 (World Health Organization, 2011m)
EE: 17.4% (The World Bank, 2009b)
ALR: 81% (CIA World Factbook, 2012m)
Country: Morocco
MV: 98% (World Health Organization, 2011n)
ACW: 83% (World Health Organization, 2011n)
PR: 67% (CIA World Factbook, 2012n)
LE: 73 years (World Health Organization, 2011n)
HCE: $165 (World Health Organization, 2011n)
HWC: 15.1 (World Health Organization, 2011n)
EE: 25.7% (The World Bank, 2009b)
ALR: 56% (The World Bank, 2009a)
Country: Mozambique
MV: 77% (World Health Organization, 2011o)
ACW: 45% (World Health Organization, 2011o)
PR: 20.7% (CIA World Factbook, 2012o)
LE: 49 years (World Health Organization, 2011o)
HCE: $22 (World Health Organization, 2011o)
HWC: 3.4 (World Health Organization, 2011o)
EE: 15.2% (CIA World Factbook, 2012o)
ALR: 55% (The World Bank, 2009a)
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Country: Namibia
MV: 76% (World Health Organization, 2011p)
ACW: 85% (World Health Organization, 2011p)
PR: 12.8% (CIA World Factbook, 2012p)
LE: 57 years (World Health Organization, 2011p)
HCE: $245 (World Health Organization, 2011p)
HWC: 31.5 (World Health Organization, 2011p)
EE: 22.4% (The World Bank, 2009b)
ALR: 89% (The World Bank, 2009a)
Country: Somalia
MV: 24% (World Health Organization, 2011q)
ACW: 22% (World Health Organization, 2011q)
PR: 4.3% (CIA World Factbook, 2012q)
LE: 51 years (World Health Organization, 2011q)
HCE: $30 (World Health Organization, 2011q)
HWC: 1.5 (World Health Organization, 2011q)
EE: 6.3% (CIA World Factbook, 2012q)
ALR: 42% (CIA World Factbook, 2012q)
Country: South Africa
MV: 62% (World Health Organization, 2011r)
ACW: 78% (World Health Organization, 2011r)
PR: 17.3% (CIA World Factbook, 2012r)
LE: 54 years (World Health Organization, 2011r)
HCE: $450 (World Health Organization, 2011r)
HWC: 48.5 (World Health Organization, 2011r)
EE: 16.9% (The World Bank, 2009b)
ALR: 89% (The World Bank, 2009a)
Country: Sudan
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MV: 82% (World Health Organization, 2011s)
ACW: 62% (World Health Organization, 2011s)
PR: 36.3% (CIA World Factbook, 2012s)
LE: 59 years (World Health Organization, 2011s)
HCE: $88 (World Health Organization, 2011s)
HWC: 11.2 (World Health Organization, 2011s)
EE: 15% (The World Bank, 2009b)
ALR: 71% (CIA World Factbook, 2012s)
Country: Zambia
MV: 85% (World Health Organization, 2011t)
ACW: 60% (World Health Organization, 2011t)
PR: 22% (CIA World Factbook, 2012t)
LE: 48 years (World Health Organization, 2011t)
HCE: $64 (World Health Organization, 2011t)
HWC: 7.7 (World Health Organization, 2011t)
EE: 22% (The World Bank, 2009b)
ALR: 71% (The World Bank, 2009a)
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Appendix #2
Scatter Plots
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Work Journal
Sunday April 1, 2012
•

Finalized my topic: decided to specifically look at measles because it is a
vaccination that has been incredible successful at preventing the disease
in more developed nations. I first want to see if there is a correlation
between the vaccination level and the number of cases, looking at it using
a time series. This is to show that using measles vaccination is a good
variable to pick for access to healthcare because vaccinations are a
simple and effective way for preventative healthcare. Next using
vaccination rates as a variable to represent access to healthcare, I want to
look at the environment, government structure, economic status of
differing countries to try to determine what variables play a greater role in
access to healthcare for a given population.

•

Looked at the WHO country specific data (immunization rate broken down
to urban and rural, healthcare expenditure as percentage as GDP, and
healthcare infrastructure data). Then organized countries based on Low
or high level of GDP for the African region and European Region.
Proceeded to download the country reports and immunization records for
each of the 28 countries I am going to use to analyze later

•

Starting looking for articles that discussed the economics (cost-benefits of
immunization programs), the measles vaccination itself (its effectiveness
and safeness) and barriers to healthcare in developing countries focusing
on the urban/rural problems and possible solutions to these problems.

Monday April 2, 2012
•

Met with Dr. Viladent. Talked over idea of project, discussed looking at
the individual country’s ministries of health website to further gather data
(# of healthcare facilities in the country and if they have special programs
to help the rural areas or to overcome other obstacles such as poor
infrastructure).
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•

Make sure to include variable bias in the discussion section (that the
variables included in model do not account for everything, economic
variables don’t account for inequality, and that the reported variables could
be skewed by the governement, especially if it is corrupt, to make the
country seem to be more developed).

Tuesday April 3, 2012 updated Friday April 27, 2012
•

Emailed Pascale Wismer to get in contact with Paul-Henri Arni, ICRC
Health care in Danger for an interview

•

As of April 27, 2012 I have not received a response.

Thursday April 5, 2012
•

Graphed a time series of the % of one year olds vaccinated to get an idea
of the overall global trend. Challenges presented: availability of
vaccination percentage from long time ago. So just looked at 2002-2011

•

Things to do: break time series down by region

Monday- Wednesday April 9-11, 2012
•

Complied data from the internet into excel, so it will be possible to use
software to run the regression. Pick the variables to use was difficult to
start I am going to included: Measles vaccination, Access to clean water,
Paved road percentage, life expectancy, healthcare work force, healthcare
expenditure, education expenditure, and adult literacy rate, but will run
multiple regressions play around with differing variables to find the best rsquared and most statistically significant variables. I am going to run the
regression using the ordinary least squares method (OLS).

Percentage of 1 year olds vaccinated against measles (MV)
Variables to represent Economy:
GDP per Capital (GDPPC) Measured in US dollars
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Variables to represent Infrastructure:
Access to clean water and sanitation (ACW and ACS) measured by # of people
who use improved sanitation facility and water filter
Percentage of total roads that is paved (Cia world fact book). (PR)
Variables to represent Health care sector:
Life Expectancy (LE) Measured in years
Healthcare workforce (HCW)= # of nurses, midwives and physicians for 10,000
citizens
Health expenditure (HCE) measured in US$ per capita per year
Variables to represent access to education:
Adult Literacy Rate (ALR) % of literate people ages 15 and above
EE= education expenditure percentage of GDP spent annually to improve
education.
Urban population (UP) measured in a percentage
Different regression Variables to represent governement:
Dummy variable if there is a program
Corruption indices Transparency
Friday April 13th 2012
•

Talked to Viladent about how many variables I was using and what the
best ones to use might be. He recommends using mostly health,
education and infrastructure variables. Especially healthcare and
education expenditure. Corruption could be used in discussion to maybe
discuss an outlier, but it could be a very biased variable and impact my
results. Same with economic variables, GDP per capita does nothing to
account for inequality. Finally, it was recommended that I use the put all
the variables in and work my way down to a final model to see what
variables create the best results.

Monday and Tuesday April 16th and 17th, 2012
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•

Graphed scatter plots

•

Ran regressions ran into a few problems with negative coefficients with
the healthcare variables, they were removed one at a time, problem
persisted, so in the end removed them all and had a model that used only
infrastructure and education variables. Deals with the negative coefficient
problem, but makes the model more limited, however I this point I don’t
believe I have time to collected data on different variables and start over in
the regression process. Future study?

Wednesday- Tuesday April 18th-23rd, 2012
•

Write, write, write

Tuesday April, 23rd 2012
•

Talked to Viladent about the specifics of citations of World Health
Organization releases.

Wednesday April 24th, 2012
•

Created powerpoint and hand out for presentation

•

Went over results with Dr. Viladent and discussed best way to report them
in the result section of my ISP

Thursday-Friday April 26th-27th 2012
•

Finished up citations

•

Editing ISP
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